By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Topical acne agents > Tazarotene cream, gel, lotion, and foam > Tazarotene Topical Dosage
Topical acne agents
https://themeditary.com/dosage-information/tazarotene-topical-dosage-6808.html

Tazarotene Topical Dosage

Drug Detail:Tazarotene cream, gel, lotion, and foam (Tazarotene topical [ ta-zar-oh-teen ])

Drug Class: Topical acne agents Topical antipsoriatics

Contents
Uses Warnings Before Taking Dosage Side effects Interactions FAQ

Usual Adult Dose for Plaque Psoriasis

Initial dose: Apply a thin film of 0.05% gel or cream once a day in the evening to cover only the psoriatic lesions

  • Increase to 0.1% if tolerated and medically indicated

Comments:
  • Apply to dry skin; if a bath or shower is taken prior to application, allow time for skin to dry before applying; if emollients are used, they should be applied at least 1 hour prior.
  • Avoid applying gel or cream on unaffected skin as it may be more susceptible to irritation.
  • The safety of gel use on more than 20% body surface area has not been established and is not recommended.

Uses:
  • For the topical treatment of plaque psoriasis

Usual Adult Dose for Acne

Apply a thin layer of 0.1% gel/cream/foam once a day in the evening to cover acne lesions

Comments:

  • Cleanse the face gently and dry before application.
  • Use sunscreen and wear protective clothing while using this drug.

Use: For the topical treatment of acne vulgaris

Usual Adult Dose for Skin Pigmentation Disorder

Apply pea-sized amount once a day at bedtime to lightly cover entire face, including the eyelids, if desired

Comments:

  • Remove makeup and after washing face and allow skin to completely dry before applying; emollients/moisturizers may be applied before this cream, however, allow to absorb and completely dry before applying this cream; facial moisturizers may be used as frequently as desired.
  • This cream does not eliminate or prevent wrinkles or restore more youthful skin.
  • This cream does not reverse photoaging or repair sun damaged skin; it does not mitigate coarse or deep wrinkling, tactile roughness, telangiectasia, skin laxity, keratinocytic atypia, melanocytic atypia, or dermal elastosis.
  • The safety and effectiveness for the prevention and treatment of actinic keratoses, skin neoplasms, or lentigo maligna have not been established.

Use: As an adjunctive agent for use in the mitigation (palliation) of facial fine wrinkling, facial, mottled hyper and hypopigmentation and benign facial lentigines in patients who use comprehensive skin care and sunlight avoidance programs.

Usual Pediatric Dose for Acne

Age: 12 years or older:
Apply a thin layer of 0.1% gel/cream/foam once a day in the evening to cover acne lesions

Comments:

  • Cleanse the face gently and dry before application.
  • Use sunscreen and wear protective clothing while using this drug.

Use: For the topical treatment of acne vulgaris

Usual Pediatric Dose for Plaque Psoriasis

Age: 12 years or older:
Initial dose: Apply a thin film of 0.05% gel or cream once a day in the evening to cover only the psoriatic lesions

  • Increase to 0.1% if tolerated and medically indicated

Comments:
  • Apply to dry skin; if a bath or shower is taken prior to application, allow time for skin to dry before applying; if emollients are used, they should be applied at least 1 hour prior.
  • Avoid applying gel or cream on unaffected skin as it may be more susceptible to irritation.
  • The safety of gel use on more than 20% body surface area has not been established and is not recommended.

Uses:
  • For the topical treatment of plaque psoriasis

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

CONTRAINDICATIONS:

  • Pregnancy
  • Hypersensitivity to any product components

Safety and efficacy have not been established in patients younger than 12 years
Safety and efficacy of Avage(R) cream have not been established in patients younger than 17 years

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

  • For topical use only; not for ophthalmic, oral, or intravaginal use
  • Avoid eyes, mouth, lips, and mucous membranes; if contact with mucous membranes occurs, rinse thoroughly with water
  • Apply to clean, dry skin; if emollients or moisturizers are applied prior, allow time for skin to absorb and dry completely prior to application of this drug
  • Wash hands thoroughly after application
  • Patients should use effective sunscreens and protective clothing while using this drug

Foam:
  • Shake can before use; hold can at an upright angle and press firmly to dispense
  • Dispense a small amount of foam into palm of hand; using fingertips, apply only enough foam to lightly cover the entire affected area of face and/or upper trunk with a thin layer; gently massage foam into skin until it disappears

Storage requirements:
Foam: Store upright, protect from freezing; flammable

General:
  • Treatment with lower concentration is associated with lower incidence of local adverse events; however, treatment with higher concentration gives faster and numerically higher response rates.
  • Safety of gel use on more than 20% body surface area has not been established.

Monitoring:
  • Monitor for excessive skin irritation

Patient advice:
  • Patients should be instructed on proper use and need to wash hands thoroughly after application; accidental transfer into eyes, mouth, or other mucous membranes should be avoided, if contact occurs, rinse thoroughly with water.
  • Patients should understand that this drug may cause skin irritation and a healthcare provider should be closely monitoring their clinical response and skin tolerance; moisturizers may help and can be used as needed, however, patients should contact their healthcare provider for excessive skin irritation.
  • Patients should be instructed to wear effective sunscreen and wear protective clothing during therapy.
  • Women of childbearing potential should understand the potential risk to a fetus if they were to become pregnant; effective contraception is advised during pregnancy.

Frequently asked questions

  • Is Tazorac better than Retin-A?
  • How long should you use Duobrii?
  • What happens if you use too much Duobrii?
  • What does it do to your skin?
  • What are the different brands of tazarotene?
  • Can Tazorac and Differin be used together?
Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by